Table 2. Reproductive statistics for Orlando strain and transgenic Ae. aegypti.

Cycle	Parameter	Orlando	EGFP	autoHermes	pBacMOS
1	Preoviposition	2.79 ± 0.07a	1.95 ± 0.05b	2.05 ± 0.05b	1.36 ± 0.14c
	Fecundity	89.74 ± 7.57a	22.86 ± 4.81b	57.94 ± 8.26c	46.53 ± 6.83bc
	Sex ratio	39.05	50	41.79	61.76
	% sterile females	13.2	47.22	32.26	30.56
2	Preoviposition	2.26 ± 0.11a	2.06 ± 0.34a	2.25 ± 0.23a	2.44 ± 0.26a
	Fecundity	51.64 ± 7.66a	21.02 ± 4.75b	41.21 ± 7.61ab	30.76 ± 7.04ab
	Sex ratio	47.44	80	40.29	52.94
	% sterile females	33.33	46.67	31.03	45.55
3	Preoviposition	2.23 ± 0.14ab	2.67 ± 0.40a	1.78 ± 0.15b	2.92 ± 0.15a
	Fecundity	60.37 ± 8.05a	19.44 ± 4.99b	50.21 ± 8.68a	41.87 ± 6.77ab
	Sex ratio	38.25	0	43.13	51.56
	% sterile females	25.71	40.74	32.14	22.58
4	Preoviposition	3.58 ± 0.75a	1.73 ± 0.47a	2.71 ± 0.50a	2.47 ± 0.30a
	Fecundity	46.36 ± 8.80a	13.57 ± 4.58b	35.65 ± 7.84ab	27.90 ± 6.50ab
	Sex ratio	31.09	33.33	26.73	40
	% sterile females	28.57	52.17	46.15	48.28

Mean preoviposition period in days (±SE), mean lifetime fecundity (±SE), sex ratio of offspring (i.e., percentage female progeny produced), and percentage of F₁ females that were sterile (i.e., either laid eggs that failed to hatch or did not lay eggs) for wild-type and transgenic Ae. aegypti for consecutive gonotrophic cycles 1, 2, 3, and 4. Means followed by the same letters within rows are not significantly different at the 0.05 level (ANOVA) of significance.